Cumberland Pharmaceuticals CPIX Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's intangible purchases?
- Cumberland Pharmaceuticals (CPIX) reported intangible purchases of $19.16K in Q1 2026.
- How has Cumberland Pharmaceuticals's intangible purchases changed year-over-year?
- Cumberland Pharmaceuticals's intangible purchases increased by 5.3% year-over-year, from $18.2K to $19.16K.
- What is the long-term trend for Cumberland Pharmaceuticals's intangible purchases?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's intangible purchases has grown at a -23.8% compound annual growth rate (CAGR), from $250.93K to $84.4K.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.